Characterization of Transthyretin Mutation G47V Associated with Hereditary Cardiac Amyloidosis
Cardiology · 2024
DOI: 10.1159/000538081 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cardiology, 2024. Verfasst von Xiaopeng He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, hexp@zju.edu.cn. Hauptthemen laut MEDLINE: Prealbumin, Mutation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Amyloidosis caused by TTR mutations (ATTRv) is a rare inherited and autosomal dominant disease. More than 150 mutants of TTR have been reported, whereas some of them remain to be investigated.
Methods
A 52-year-old male presented with heart failure and clinically diagnosed ATTR cardiac amyloidosis (ATTR-CA) was recruited. Whole-exome sequencing (WES) was performed. Biochemical and biophysical experiments characterized protein stability using urea-mediated tryptophan fluorescence. Drug response was analyzed by fibril formation assay. Finally, tetramer TTR concentration in patient’s serum sample was measured by ultra-performance liquid chromatography (UPLC).
Results
For the proband, WES revealed a mutation (c.200G>T; p.Gly67Val and referred to as G47V) in TTR gene. Biochemical and biophysical kinetics study showed that the thermodynamic stability of G47V-TTR (Cm = 2.4 m) was significantly lower than that of WT-TTR (Cm = 3.4 m) and comparable to that of L55P-TTR (Cm = 2.3 m), an early age-of-onset mutation. G47V:WT-TTR heterozygous tetramer kinetic stability (t1/2 = 1.4 h) was further compromised compared to that of the homozygous G47V-TTR (t1/2 = 3.1 h). Among three small molecule stabilizers, AG10 exhibited the best inhibition of the fibrillation of G47V-TTR homozygous protein. Using a UPLC assay, nearly 40% of TTR in this patient was calculated to be non-tetrameric.
Conclusion
In this work, we reported a patient presented early onset of clinically typical ATTR-CA due to G47V-TTR mutation. Our work for the first time not only characterized the biochemical properties of G47V-TTR mutation, but also provided hints for the pathogenicity of this mutation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, hexp@zju.edu.cn.
- CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Science, Dalian, China.
- Department of Chemistry, University of Chinese Academy of Sciences, Beijing, China.
- Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zitieren
APA
He, X., Wang, M., Sun, J., Yu, Z., Hu, X., Liu, Y., & Lin, X. (2024). Characterization of Transthyretin Mutation G47V Associated with Hereditary Cardiac Amyloidosis. Cardiology. https://doi.org/10.1159/000538081
Vancouver
He X, Wang M, Sun J, Yu Z, Hu X, Liu Y, et al. Characterization of Transthyretin Mutation G47V Associated with Hereditary Cardiac Amyloidosis. Cardiology. 2024. doi:10.1159/000538081
BibTeX
@article{He2024,
author = {He, Xiaopeng and Wang, Mengdie and Sun, Jialu and Yu, Zhengyang and Hu, Xinyang and Liu, Yu and Lin, Xiaoping},
title = {Characterization of Transthyretin Mutation G47V Associated with Hereditary Cardiac Amyloidosis},
journal = {Cardiology},
year = {2024},
doi = {10.1159/000538081}
}
EUVIMED